Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Calista Ming

Optometrist Davie, FL Doctor of Optometry

NPI 1871946855 CMS profile 1432989

3200 S University Dr, Terry Building 1402, Davie, FL 33328

Open in the dashboard

General payments

$78,248

268 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Calista Ming of Davie, FL is reported in the CMS Open Payments database as having received $78,248 across 268 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $11,354 35
2024 General $18,499 61
2023 General $16,854 69
2022 General $7,873 41
2021 General $17,868 38
2020 General $5,205 15
2019 General $594 9

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Calista Ming
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Calista Ming were reported at $11,354. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Calista Ming Optometrist median Middle half National median
2019 $594 $159 $67–$371 $163
2020 $5,205 $72 $29–$165 $114
2021 $17,868 $125 $46–$292 $132
2022 $7,873 $162 $66–$374 $149
2023 $16,854 $177 $72–$406 $160
2024 $18,499 $188 $77–$427 $164
2025 $11,354 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Bausch & Lomb Americas Inc. $44,105 106 payments
  2. Bausch & Lomb, a division of Bausch Health US, LLC $22,825 47 payments
  3. Alcon Vision LLC $4,431 31 payments
  4. CooperVision Inc. $3,157 41 payments
  5. Johnson & Johnson Vision Care, Inc. $2,421 25 payments
  6. Glaukos Corporation $286 7 payments
  7. Astellas Pharma US Inc $246 2 payments
  8. Allergan Inc. $238 2 payments
  9. AbbVie, Inc. $124 1 payment
  10. Oyster Point Pharma, Inc. $122 1 payment
  11. Other $292 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $36,653 22 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $18,825 23 payments
  3. Travel and Lodging $9,533 75 payments
  4. Food and Beverage $6,238 136 payments
  5. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $4,500 3 payments
  6. Consulting Fee $2,400 7 payments
  7. Gift $99 2 payments
Products named General payments · program years 2019–2025
  1. ZENLENS $37,286 71 payments
  2. ZEN LENS $27,071 35 payments
  3. Acuvue $2,395 24 payments
  4. Clariti Contact Lens $2,387 24 payments
  5. AIR OPTIX $2,116 13 payments
  6. INFUSE $1,047 18 payments
  7. ALDEN SCLERAL ZENLENS $544 14 payments
  8. DAILIES $364 5 payments
  9. VUITY $362 3 payments
  10. MiSight Contact Lens $329 5 payments
  11. Other $2,906 58 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

268 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record